FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Corporate Results

Back
Vaishali Pharma standalone net profit declines 40.10% in the September 2025 quarter
(19-Nov-2025, 12:36 Hours IST)  
Net profit of Vaishali Pharma declined 40.10% to Rs 1.18 crore in the quarter ended September 2025 as against Rs 1.97 crore during the previous quarter ended September 2024. Sales rose 60.89% to Rs 33.45 crore in the quarter ended September 2025 as against Rs 20.79 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales33.4520.79 61
OPM %4.1311.64 -
PBDT1.822.75 -34
PBT1.652.63 -37
NP1.181.97 -40

Powered by Capital Market - Live News

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)